Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jihye Paik

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Aging Cell|November 28, 2017
FOXO protects against age-progressive axonal degenerationInah Hwang, Hwanhee Oh, Evan Santo, et al.
Neuron|September 11, 2018
FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult NeurogenesisIris Schäffner, Georgia Minakaki, M Amir Khan, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment ResistanceSoo-Yeon Hwang, Helgi Nikolli, Belem Yoval-Sánchez, et al.
The EMBO Journal|August 28, 2019
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalizationFei Li, Zhong Deng, Ling Zhang, et al.
Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications|July 2, 2026
BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistanceSoo-Yeon Hwang, Xiangao Huang, Helgi Nikolli, et al.
Science (New York, N.Y.)|November 7, 2015
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHJihye Yun, Edouard Mullarky, Changyuan Lu, et al.
Blood Advances|June 16, 2023
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphomaFiona Brown-Burke, Inah Hwang, Shelby Sloan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Aging Cell|November 28, 2017
FOXO protects against age-progressive axonal degenerationInah Hwang, Hwanhee Oh, Evan Santo, et al.
Neuron|September 11, 2018
FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult NeurogenesisIris Schäffner, Georgia Minakaki, M Amir Khan, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment ResistanceSoo-Yeon Hwang, Helgi Nikolli, Belem Yoval-Sánchez, et al.
The EMBO Journal|August 28, 2019
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalizationFei Li, Zhong Deng, Ling Zhang, et al.
Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
The Journal of Clinical Investigation|July 2, 2019
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancerAdeline Berger, Nicholas J Brady, Rohan Bareja, et al.
Nature Communications|July 2, 2026
BRG1-mediated suppression of ferroptosis underlies BTK inhibitor resistanceSoo-Yeon Hwang, Xiangao Huang, Helgi Nikolli, et al.
Science (New York, N.Y.)|November 7, 2015
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDHJihye Yun, Edouard Mullarky, Changyuan Lu, et al.
Blood Advances|June 16, 2023
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphomaFiona Brown-Burke, Inah Hwang, Shelby Sloan, et al.
Pageof 4